Tuning the inflammatory response to silver nanoparticles via quercetin in Caco-2 (co-)cultures as model of the human intestinal mucosa

Toxicology Letters

Volumn 253, Issue , 2016, Pages 36-45

  Martirosyan, Alina ^a,b   Grintzalis, Konstantinos ^a,c   Polet, Madeleine ^a   Laloux, Laurie ^a   Schneider, Yves Jacques ^a  

^a UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

^b AARHUS UNIVERSITY   (Denmark)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Gastrointestinal tract; Inflammatory response; Oxidative and nitrosative stress; Quercetin; Silver nanoparticles

Indexed keywords

ACID PHOSPHATASE; ALKALINE PHOSPHATASE; CATALASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; INTERLEUKIN 8; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; SILVER NANOPARTICLE; SUPEROXIDE; THIOL GROUP; ANTIINFLAMMATORY AGENT; METAL NANOPARTICLE; SILVER DERIVATIVE;

AEROBIC METABOLISM; ARTICLE; CACO 2 CELL LINE; CELL VIABILITY; COCULTURE; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE RELEASE; CYTOTOXICITY; DOWN REGULATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INTESTINE MUCOSA; LIPID PEROXIDATION; MTT ASSAY; NITROSATIVE STRESS; OXIDATIVE STRESS; PHOTON CORRELATION SPECTROSCOPY; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCANNING ELECTRON MICROSCOPY; TRANSMISSION ELECTRON MICROSCOPY; X RAY ANALYSIS; CACO-2 CELL LINE; CELL PROTECTION; CELL SURVIVAL; CHEMICALLY INDUCED; DOSE RESPONSE; DRUG EFFECTS; INFLAMMATION; METABOLISM; PATHOLOGY; RISK ASSESSMENT;

ANTI-INFLAMMATORY AGENTS; CACO-2 CELLS; CELL SURVIVAL; COCULTURE TECHNIQUES; CYTOPROTECTION; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; LIPID PEROXIDATION; METAL NANOPARTICLES; OXIDATIVE STRESS; QUERCETIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RISK ASSESSMENT; SILVER COMPOUNDS;

EID: 84973130811     PISSN: 03784274     EISSN: 18793169     Source Type: Journal    
DOI: 10.1016/j.toxlet.2016.04.018     Document Type: Article

References (53)

1. ACGIH Silver and compounds. TLV Chemical Substances 2001, ACGIH. 7th edition.
2. Aw T.Y. Molecular and cellular responses to oxidative stress and changes in oxidation-reduction imbalance in the intestine. Am. J. Clin. Nutr. 1999, 70(4):557-565.
3. Beecher G. Overview of dietary flavonoids: nomenclature, occurrence and intake. J. Nutr. 2003, 133(10):3248S-3254S.
4. Benn T., Cavanagha B., Hristovskib K., Posnerc J., Westerhoffa P. The release of nanosilver from consumer products used in the home. J. Environ. Qual. 2010, 39(6):1875-1882.
5. Bhol K., Schechter P. Effects of nanocrystalline silver (NPI 32101) in a rat model of ulcerative colitis. Dig. Dis. Sci. 2007, 52(10):2732-4272.
6. Castro L., Rodriguez M., Radi R. Aconitase is readily inactivated by peroxynitrite, but not by its precursor, nitric oxide. J. Biol. Chem. 1994, 269(47):29409-29415.
7. de Vries J.H., Janssen P.L., Hollman P.C., van Staveren W.A., Katan M.B. Consumption of quercetin and kaempferol in free-living subjects eating a variety of diets. Cancer Lett. 1997, 114(1-2):141-144.
8. des Rieux A., Fievez V., Théate I., Mast J., Préat V., Schneider Y.J. An improved in vitro model of human intestinal follicle-associated epithelium to study nanoparticle transport by M cells. Eur. J. Pharm. Sci 2007, 30(5):380-391.
9. European Commission Occupational Exposure Limits: Recommendations of the Scientific Expert Group 1991-92. EUR 15091 1994, European Commission, Luxembourg.
10. Foldbjerg R., Jiang X., Miclăuş T., Chen C., Autrupa H., Beer C. Silver nanoparticles-wolves in sheep's clothing?. Toxicol. Res. 2015, 4:563-575.
11. Geranio L., Heuberger M., Nowack B. The behavior of silver nanotextiles during washing. Environ. Sci. Technol. 2009, 4(21):8113-8118.
12. Gibson R.S., Scythes C.A. Chromium, Selenium, and Other trace-element intakes of a selected sample of Canadian premenopausal women. Biol. Trace Elem. Res. 1984, 6(2):105-116.
13. Gliga A.R., Skoglund S., Wallinder I.O., Fadeel B., Karlsson H.L. Size-dependent cytotoxicity of silver nanoparticles in human lung cells: the role of cellular uptake, agglomeration and Ag release. Part Fibre Toxicol. 2014, 11:11.
14. Godber B.L., Doel J.J., Sapkota G.P., Blake D.R., Stevens C.R., Eisenthal R., Harrison R. Reduction of nitrite to nitric oxide catalyzed by xanthine oxidoreductase. J. Biol. Chem. 2000, 275(11):7757-7763.
15. Grintzalis K., Papapostolou I., Zisimopoulos D., Stamatiou I., Georgiou C.D. Multiparametric protocol for the determination of thiol redox state in living matter. Free Rad Biol Med 2014, 74:85-98.
16. Grintzalis K., Georgiou C.D., Schneider Y.J. An accurate and sensitive Coomassie Brilliant Blue G-250-based assay for protein determination. Anal. Biochem. 2015, 1:28-30.
17. Grossi L., McHugh K., Collins S.M. On the specificity of altered muscle function in experimental colitis in rats. Gastroenterology 1993, 104(4):1049-1056.
18. Hadrup N., Lam H.R. Oral toxicity of silver ions, silver nanoparticles and colloidal silver-a review. Regul. Toxicol. Pharmacol. 2014, 68(1):1-7.
19. Hamilton E.I., Minski M.J. Abundance of the chemical elements in man's diet and possible relations with environmental factors. Sci. Total Environ. 1973, 1(4):375-394.
20. Hatipoglu M.K., Keleştemur S., Altunbek M., Culha M. Source of cytotoxicity in a colloidal silver nanoparticle suspension. Nanotechnology 2015, 26(19):195103.
21. Hausladen A., Fridovich I. Superoxide and peroxynitrite inactivate aconitases, but nitric oxide does not. J. Biol. Chem. 1994, 269(47):29405-29408.
22. Hoffmann E., Dittrich-Breiholz O., Holtmann H., Kracht M. Multiple control of interleukin-8 gene expression. J. Leukoc. Biol. 2002, 72(5):847-855.
23. Jacobson K., McHugh K., Collins S.M. Experimental colitis alters myenteric nerve function at inflamed and noninflamed sites in the rat. Gastroenterology 1995, 109(3):718-722.
24. Kolios G., Valatas V., Ward S.G. Nitric oxide in inflammatory bowel disease: a universal messenger in an unsolved puzzle. Immunology 2004, 113(4):427-437.
25. Kulthong K., Srisung S., Boonpavanitchakul K., Kangwansupamonkon W., Maniratanachote R. Determination of silver nanoparticle release from antibacterial fabrics into artificial sweat. Part Fibre Toxicol. 2010, 7:8.
26. Lebed P.J., Grisales J.O., Keunchkarian S., Gotta J., Giambelluca M., Castells C. Rapid and sensitive gradient liquid chromatography method for the quantitation of 2-hydroxyethidium ion from neutrophils. Anal Meth. 2011, 3:593-598.
27. Manach C., Scalbert A., Morand C., Rémésy C., Jiménez L. Polyphenols: food sources and bioavailability. Am. J. Clin. Nutr. 2004, 79(5):727-747.
28. Mannervik B., Guthenberg C. Glutathione transferase (human placenta). Methods Enzymol. 1981, 77:231-235.
29. Marcinkiewicz J., Chain B., Nowak B., Grabowska A., Bryniarski K., Baran J. Antimicrobial and cytotoxic activity of hypochlorous acid: interactions with taurine and nitrite. Inflamm. Res. 2000, 49(6):280-289.
30. Martin G.R., Wallace J.L. Gastrointestinal inflammation: a central component of mucosal defense and repair. Exp. Biol. Med. 2006, 231(2):130-137.
31. Martirosyan A., Bazes A., Schneider Y.J. In vitro toxicity assessment of silver nanoparticles in the presence of phenolic compounds-preventive agents against the harmful effect?. Nanotoxicology 2014, 8(5):573-582.
32. McCafferty D.M. Peroxynitrite and inflammatory bowel disease. Gut 2000, 46:436-439.
33. McCormack G., Moriarty D., O'Donoghue D.P., McCormick P.A., Sheahan K., Baird A.W. Tissue cytokine and chemokine expression in inflammatory bowel disease. Inflamm. Res. 2001, 50:491-495.
34. Menconi M.J., Unno N., Smith M., Aguirre D.E., Fink M.P. Nitric oxide donor-induced hyperpermeability of cultured intestinal epithelial monolayers: role of superoxide radical, hydroxyl radical, and peroxynitrite. Biochim. Biophys. Acta 1998, 1425:189-203.
35. Middleton E., Kandaswami C., Theoharides T.C. The effect of flavonoids on mammalian cells: implications for inflammation, heart disease and cancer. Pharmacol. Rev. 2000, 52(4):651-674.
36. Mudter J., Neurath M.F. IL-6 signaling in inflammatory bowel disease: pathophysiological role and clinical relevance. Inflamm. Bowel Dis 2007, 13(8):1016-1023.
37. Munkres D.K., Rana S.R., Goldstein E. Genetically determined conidial longevity is positively correlated with superoxide dismutase, catalase, glutathione peroxidase, cytochrome c, peroxidase, and ascorbate free radical reductase activities in Neurospora crassa. Mech. Ageing Dev 1984, 24:83-100.
38. Nagase S., Takemura K., Ueda A., Hirayama A., Aoyagi K., Kondoh M., Koyama A. A novel nonenzymatic pathway for the generation of nitric oxide by the reaction of hydrogen peroxide and D- or L-arginine. Biochem. Biophys. Res. Commun. 1997, 233:150-153.
39. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 1997, 15:351-369.
40. Nel A., Xia T., Mädler L., Li N. Toxic potential of materials at the nanolevel. Science 2006, 311(5761):622-627.
41. Oberdörster G., Maynard A., Donaldson K., Castranova V., Fitzpatrick J., Ausman K., Carter J., Karn B., Kreyling W., Lai D., Olin S., Monteiro-Riviere N., Warheit D., Yang H. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol. 2005, 2:8.
42. Rizzello L., Pompa P.P. Nanosilver-based antibacterial drugs and devices: mechanisms, methodological drawbacks, and guidelines. Chem. Soc. Rev. 2014, 43(5):1501-1518.
43. Salzman A.L., Menconi M.J., Unno N., Ezzell R.M., Casey D.M., Gonzalez P.K., Fink M.P. Nitric oxide dilates tight junctions and depletes ATP in cultured Caco-2BBe intestinal epithelial monolayers. Am. J. Physiol. 1995, 268:G361-373.
44. Sergent T., Piront N., Meurice J., Toussaint O., Schneider Y.J. Anti-inflammatory effects of dietary phenolic compounds in an in vitro model of inflamed human intestinal epithelium. Chem. Biol. Interact. 2010, 188(3):659-667.
45. Suzuki T., Hara H. Quercetin enhances intestinal barrier function through the assembly of zonnula occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. J. Nutr. 2009, 139(5):965-974.
46. van der Woude H., Gliszczyńska-Swigło A., Struijs K., Smeets A., Alink G.M., Rietjens I.M. Biphasic modulation of cell proliferation by quercetin at concentrations physiologically relevant in humans. Cancer Lett. 2003, 200(1):41-47.
47. van der Zande M., Vandebriel R.J., Van Doren E., Kramer E., Herrera Rivera Z., Serrano-Rojero C.S., Gremmer E.R., Mast J., Peters R.J., Hollman P.C., Hendriksen P.J., Marvin H.J., Peijnenburg A.A., Bouwmeester H. Distribution, elimination, and toxicity of silver nanoparticles and silver ions in rats after 28-day oral exposure. ACS Nano 2012, 6(8):7427-7442.
48. Vignoli A.L., Srivastava R.C., Stammati A., Turco L., Tanori M., Zucco F. Nitric oxide production in Caco-2 cells exposed to different inducers, inhibitors and natural toxins. Toxicol. In Vitro 2001, 15:289-295.
49. Wallace J.L., Miller M.J. Nitric oxide in mucosal defense: a little goes a long way. Gastroenterology 2000, 119:512-520.
50. Wang H., Joseph J.A. Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader. Free Radic. Biol. Med. 1999, 27(5-6):612-616.
51. Wijnhoven S.W.P., Peijnenburg W.J.G.M., Herberts C.A., et al. Nano-silver: a review of available data and knowledge gaps in human and environmental risk assessment. Nanotoxicology 2009, 3(2):109-138.
52. Wink D.A., Hanbauer I., Krishna M.C., DeGraff W., Gamson J., Mitchell J.B. Nitric oxide protects against cellular damage and cytotoxicity from reactive oxygen species. Proc. Natl. Acad. Sci. U.S.A. 1993, 90(21):9813-9817.
53. Yamamoto A., Tatsumi H., Maruyama M., Uchiyama T., Okada N., Fujita T. Modulation of intestinal permeability by nitric oxide donors: implications in intestinal delivery of poorly absorbable drugs. J. Pharmacol. Exp. Ther. 2001, 296(1):84-90.